{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:10:12Z","timestamp":1792044612780,"version":"4.4.0"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The GLOW and SPOTLIGHT trials have demonstrated the efficacy of chemotherapy plus zolbetuximab for HER2-negative, claudin-18 isoform 2 (CLDN18.2)\u2013positive unresectable advanced or recurrent gastric cancer (AGC)\/gastroesophageal junction cancer. However, data on adverse events in real-world clinical practice are still insufficient. Specifically, gastritis and protein-losing enteropathy (PLE), which were not evident in either trials, are not generally recognized. This paper reports on the notable clinical course and examination findings of two cases of PLE observed in patients with unresectable AGC who were administered zolbetuximab. Case 1 involved a 66-year-old woman with HER2-negative, CLDN18.2-positive unresectable advanced gastric cancer (cT4aN1M1) with peritoneal dissemination. As a fifth-line treatment, she underwent combination therapy with capecitabine, oxaliplatin, and zolbetuximab (CAPEOX\u00a0+\u00a0Zolbe). Case 2 involved a 58-year-old woman with HER2-negative, CLDN18-positive gastric cancer (pT1aN3bM1) with extra-regional lymph node metastasis. After undergoing robot-assisted distal gastrectomy, she commenced CAPEOX\u00a0+\u00a0Zolbe therapy. In both cases, following the initiation of CAPEOX\u00a0+\u00a0Zolbe therapy, serum albumin levels decreased from 3.5\u00a0g\/dL pre-treatment to 2.2\u00a0g\/dL. Upper gastrointestinal endoscopy revealed diffuse redness and edema of the gastric mucosa. Pathological histological examination of the gastric mucosal biopsy also revealed findings consistent with PLE. A technetium-99m\u2013labeled human serum albumin scintigraphy demonstrated leakage of Tc-99m albumin into the gastrointestinal tract, leading to a diagnosis of PLE. In the two cases we experienced, we observed gastritis and PLE caused by zolbetuximab. These adverse events are not widely recognized among clinicians. However, when hypoalbuminemia occurs during zolbetuximab administration, this diagnosis should be considered.<\/jats:p>","DOI":"10.1093\/jjco\/hyaf055","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T18:59:26Z","timestamp":1742410766000},"page":"825-831","source":"Crossref","is-referenced-by-count":21,"title":["Two cases of protein-losing enteropathy induced by zolbetuximab in patients with unresectable advanced gastric cancer"],"prefix":"10.1093","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6369-6023","authenticated-orcid":false,"given":"Yoshitomo","family":"Yanagimoto","sequence":"first","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka International Cancer Institute , 3-1-69, Otemae, Chuo-ku, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka International Cancer Institute , 3-1-69, Otemae, Chuo-ku, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka International Cancer Institute , 3-1-69, Otemae, Chuo-ku, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Masuike","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka International Cancer Institute , 3-1-69, Otemae, Chuo-ku, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Ushimaru","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka International Cancer Institute , 3-1-69, Otemae, Chuo-ku, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute , 3-1-69, Otemae, Chuo-ku, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichiro","family":"Honma","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute , 3-1-69, Otemae, Chuo-ku, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Matsuura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka International Cancer Institute , 3-1-69, Otemae, Chuo-ku, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahito","family":"Sugase","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka International Cancer Institute , 3-1-69, Otemae, Chuo-ku, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kanemura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka International Cancer Institute , 3-1-69, Otemae, Chuo-ku, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka International Cancer Institute , 3-1-69, Otemae, Chuo-ku, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Kitakaze","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka International Cancer Institute , 3-1-69, Otemae, Chuo-ku, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Amisaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka International Cancer Institute , 3-1-69, Otemae, Chuo-ku, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Kubo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka International Cancer Institute , 3-1-69, Otemae, Chuo-ku, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Mukai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka International Cancer Institute , 3-1-69, Otemae, Chuo-ku, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisateru","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka International Cancer Institute , 3-1-69, Otemae, Chuo-ku, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"Sueda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka International Cancer Institute , 3-1-69, Otemae, Chuo-ku, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Kagawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka International Cancer Institute , 3-1-69, Otemae, Chuo-ku, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka International Cancer Institute , 3-1-69, Otemae, Chuo-ku, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka International Cancer Institute , 3-1-69, Otemae, Chuo-ku, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihito","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka International Cancer Institute , 3-1-69, Otemae, Chuo-ku, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Yasui","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka International Cancer Institute , 3-1-69, Otemae, Chuo-ku, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Omori","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka International Cancer Institute , 3-1-69, Otemae, Chuo-ku, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Miyata","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Osaka International Cancer Institute , 3-1-69, Otemae, Chuo-ku, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"2025070702413403200_ref1","doi-asserted-by":"publisher","first-page":"7380","DOI":"10.1128\/MCB.21.21.7380-7390.2001","article-title":"Claudin-18, a novel downstream target gene for the T\/EBP\/NKX2.1 homeodomain transcription factor, encodes lung- and stomach-specific isoforms through alternative splicing","volume":"21","author":"Niimi","year":"2001","journal-title":"Mol Cell Biol"},{"key":"2025070702413403200_ref2","doi-asserted-by":"publisher","first-page":"7624","DOI":"10.1158\/1078-0432.CCR-08-1547","article-title":"Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development","volume":"14","author":"Sahin","year":"2008","journal-title":"Clin Cancer Res"},{"key":"2025070702413403200_ref3","doi-asserted-by":"publisher","first-page":"e1523096","DOI":"10.1080\/2162402X.2018.1523096","article-title":"Characterization of zolbetuximab in pancreatic cancer models","volume":"8","author":"T\u00fcreci","year":"2019","journal-title":"Onco Targets Ther"},{"key":"2025070702413403200_ref4","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3390\/jpm11111095","article-title":"Association of CLDN18 protein expression with clinicopathological features and prognosis in advanced gastric and gastroesophageal junction adenocarcinomas","volume":"11","author":"Pellino","year":"2021","journal-title":"J Pers Med"},{"key":"2025070702413403200_ref5","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1007\/s10120-024-01518-1","article-title":"Global prevalence of claudin 18 isoform 2 in tumors of patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma","volume":"27","author":"Shitara","year":"2024","journal-title":"Gastric Cancer"},{"key":"2025070702413403200_ref6","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1038\/s41591-023-02465-7","article-title":"Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial","volume":"29","author":"Shah","year":"2023","journal-title":"Nat Med"},{"key":"2025070702413403200_ref7","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/S0140-6736(23)00620-7","article-title":"Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial","volume":"401","author":"Shitara","year":"2023","journal-title":"Lancet"},{"key":"2025070702413403200_ref8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/bjh.12078","article-title":"Gela histological scoring system for post-treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practice","volume":"160","author":"Copie-Bergman","year":"2013","journal-title":"Br J Haematol"},{"key":"2025070702413403200_ref9","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/rheumatology\/38.10.917","article-title":"A review of gastrointestinal manifestations of systemic lupus erythematosus","volume":"38","author":"Sultan","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"2025070702413403200_ref10","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1136\/gut.24.8.718","article-title":"Alpha 1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn\u2019s disease","volume":"24","author":"Karbach","year":"1983","journal-title":"Gut"},{"key":"2025070702413403200_ref11","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/1756-185X.14541","article-title":"A case of systemic lupus erythematosus presenting with intestinal lymphangiectasia-associated protein-losing enteropathy accompanying hyperinflammation","volume":"26","author":"Bekta\u015f","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"2025070702413403200_ref12","doi-asserted-by":"publisher","first-page":"e33348","DOI":"10.7759\/cureus.48348","article-title":"Post-partum fever of unknown origin: an inaugural flare of severe lupus with multisystemic involvement and hemophagocytic syndrome","volume":"15","author":"Fernandes","year":"2023","journal-title":"Cureus"},{"key":"2025070702413403200_ref13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jphs.2024.08.005","article-title":"Effect of antiemetics on zolbetuximab-induced gastric injury and emesis in ferrets","volume":"156","author":"Kinugasa","year":"2024","journal-title":"J Pharmacol Sci"},{"key":"2025070702413403200_ref14","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1056\/NEJMc2409512","article-title":"Zolbetuximab in gastric or gastroesophageal junction adenocarcinoma","volume":"391","author":"Shitara","year":"2024","journal-title":"N Engl J Med"},{"key":"2025070702413403200_ref15","first-page":"226","article-title":"A case of systemic lupus erythematosus presenting with protein-losing enteropathy","volume":"17","author":"T\u00fcrk\u00e7apar","year":"2006","journal-title":"Turk J Gastroenterol"},{"key":"2025070702413403200_ref16","doi-asserted-by":"publisher","first-page":"7458","DOI":"10.1097\/MS9.0000000000002733","article-title":"Protein-losing enteropathy as the first presentation of systemic lupus erythematosus the first case reported in Palestine with systemic review","volume":"86","author":"Abu Jheasha","year":"2024","journal-title":"Ann Med Surg"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/55\/7\/825\/62885649\/hyaf055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/55\/7\/825\/62885649\/hyaf055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T02:41:37Z","timestamp":1751856097000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/55\/7\/825\/8107846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":16,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,4,7]]},"published-print":{"date-parts":[[2025,7,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyaf055","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,4,7]]}}}